There are 702 resources available
229P - BISQUIT: A randomized phase II trial of Prebiotics and Probiotics (PreProbiotics) during chemoradiation (CRT) for patients (pts) with squamous cell carcinoma of the anal canal (SCCA)
Presenter: Rachel Riechelmann
Session: Poster Display session
230P - Should elderly patients (pts) with localized squamous cell carcinoma of the anal canal (SCCA) be treated with full chemoradiation (CRT)?
Presenter: Rachel Riechelmann
Session: Poster Display session
231P - Gender disparities in anal cancer stages survival: A seer database analysis
Presenter: Mays Alkhateeb
Session: Poster Display session
232P - Molecular alterations of interest in anal cancer: Inventory and therapeutic impact, a retrospective study
Presenter: GAUTIER BOILLET
Session: Poster Display session
233P - 3-year outcome of radical chemoradiotherapy for anal squamous cell carcinoma (ASCC) using intensity-modulated radiation therapy (IMRT) protocol at Southend Hospital
Presenter: DAVID TSANG
Session: Poster Display session
234P - Do we need molecular profiling in patients with squamous anal carcinoma?
Presenter: Cristina Smolenski
Session: Poster Display session
235P - Anal cancer in the Colombian coffee axis, epidemiological review 2001-2017
Presenter: Carlos Villegas Mejia
Session: Poster Display session
236P - Oncogenic fusions shape the landscape of actionable genomic alterations in pancreatic acinar cell carcinoma
Presenter: Sebastian Lange
Session: Poster Display session
237P - Gastrointestinal verrucous carcinoma: Recent trends and the risk of multiple primary malignancies
Presenter: Asmaa Ellaithy
Session: Poster Display session
238P - Efficacy of immunotherapy for extensive-stage small cell esophageal cancer: A multicenter real-world retrospective study
Presenter: bingjie Fan
Session: Poster Display session